Year: 2016

Banking stocks have been significantly drawing investors’ attention following Trump’s election victory and the recent rate hike by the Fed. The rate hike will likely aid top-line growth and ease the prevalent margin pressure to some extent. Today, we bring you one such stock – Synovus Financial Corp. […]

Microsoft Corp MSFT is reportedly expanding Windows 10 features as recently noted by Windows Insiders. The company is apparently bringing a “ Game Mode ” to Windows 10. According to Forbes, which quoted Twitter TWTR user WalkingCat (@h0x0d), a newer version of the operating system will include a file called – gamemode.dll – that possibly facilitates pc gaming. […]

BP plc BP recently announced that it has inked a sales and purchase agreement with PTT Public Limited Company (“PTT”) for liquefied natural gas (LNG). We expect these developments to result in stock price appreciation. Year to date, the stock has gained 19.7%, while the Zacks categorized sub industry Oil & Gas-International Integrated Market has increased by 19%. […]

The uptrend in HCA Holdings Inc. HCA explains its attractiveness in an uncertainty-ridden industry. Year to date, the share of HCA Holdings have gained 9.3% as against a loss of 10% incurred by the Zacks categorized Medical-Hospital industry […]

Hamilton, Bermuda-based offshore drilling firm, SeaDrill Limited SDRL recently reported that it has entered into a three-year agreement extension with Saudi Aramco for the AOD III jackup rig at a rate of $102,740 per day. The contract will now expire in Dec 2019. The extension of this agreement is expected to add approximately $112.5 million in contract backlog. […]

At times it is rational to hold certain stocks that have enough potential but are weighed down by tough market conditions. These stocks rally as soon as the market enters into a correction mode. Here, we have discussed one such stock, Staples, Inc […]

On Dec 27, 2016, Zacks Investment Research downgraded natural gas producer Ultra Petroleum Corporation UPLMQ to a Zacks Rank # 5 (Strong Sell). The rating downgrade reflects that the company is likely to perform below its peers and industry levels in the coming months amid the unfavorable scenario created by the currently weak sentiment for the commodity. […]

The year 2016 will likely be remembered as one of the most eventful ones. An unexpected regime change, a long overdue interest rate hike and one of the fastest economic growth in recent times have surely made a mark. […]

There seems to be no end to the plight for The Walt Disney Company ’s DIS ESPN, which has been losing subscribers over the past couple of years. Further, ESPN witnessed lower viewership for highly anticipated "Monday Night Football" in 2016. Per Nielsen data, the recent Monday night’s match between Dallas Cowboys and Detroit Lions generated an audience of 18.6 million […]

Innocoll Holdings plc INNL announced that it has received a Refusal to File letter from the FDA in connection with the New Drug Application (NDA) for its pipeline candidate, Xaracoll, (bupivacaine HCl collagen-matrix implants) for the treatment of postsurgical pain. Following the announcement, the company’s shares were down almost 50% in after-market trading session on Dec 29. Year-to-date, Innocoll’s stock has plunged almost 78.7%, underperforming the Zacks classified Medical Drugs industry which has witnessed a declined of 25.4% in the same time frame […]

The surprise victory of Republican Donald Trump in the U.S. Presidential election has turned out to be a boon in disguise for the energy sector. The billionaire real estate developer, who never held an elected office before, proposed certain changes for the oil and gas sector. […]

Health insurer Aetna Inc. AET has been grappling with a number of issues of late, which are clearly reflected in its share price underperformance relative to the sector. Year to date, the stock has gained 15.1% compared with the Zacks categorized Medical Health Maintenance Organization (HMO) industry’s increase of 21.9%. […]

Corbus Pharmaceuticals Holdings, Inc. CRBP , recently announced that it has concluded Phase II trial evaluating pipeline candidate, JBT-101 (resunab), for the treatment of cystic fibrosis (CF). Corbus’ share price has gained 17.8% in the past one month, outperforming the Zacks classified Medical-Drugs industry which has witnessed a gain of 2.5% gain in the same time frame. […]

Shares of RLI Corp . RLI have significantly underperformed the Zacks categorized Property and Casualty Insurance industry, quarter to date. While RLI Corp shares lost 7.9%, the industry gained nearly 12%. […]

ARIAD Pharmaceuticals, Inc. ARIA remains focused on the discovery, development and commercialization of breakthrough treatments for cancer. This year was a tough one for the pharma sector, which had to grapple with media and political focus on the high prices of drugs. […]